Nalaganje...

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

A cornerstone of preclinical cancer research has been the use of clonal cell lines. However, this resource has underperformed in its ability to effectively identify novel therapeutics and evaluate the heterogeneity in a patient's tumor. The patient-derived xenograft (PDX) model retains the hete...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Dobbin, Zachary C., Katre, Ashwini A., Steg, Adam D., Erickson, Britt K., Shah, Monjri M., Alvarez, Ronald D., Conner, Michael G., Schneider, David, Chen, Dongquan, Landen, Charles N.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226719/
https://ncbi.nlm.nih.gov/pubmed/25209969
Oznake: Označite
Brez oznak, prvi označite!